Moolec Science SA (NASDAQ:MLEC) Short Interest Down 52.1% in July

Moolec Science SA (NASDAQ:MLEC) saw a large decrease in short interest in July. As of July 31st, there was short interest totaling 4,512 shares, a decrease of 52.1% from the July 15th total of 9,414 shares. Based on an average daily trading volume, of 18,186 shares, the short-interest ratio is presently 0.2 days. Currently, 0.8% of the company’s stock are sold short.

Hedge Funds Weigh In On Moolec Science

An institutional investor recently bought a new stake in Moolec Science stock. Citadel Advisors LLC acquired a new stake in Moolec Science SA (NASDAQ:MLEC) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned about 0.90% of Moolec Science at the end of the most recent reporting period. 0.07% of the stock is owned by hedge funds and other institutional investors.

Moolec Science Stock Performance

MLEC traded up $0.21 on Friday, reaching $7.20. 783 shares of the stock were exchanged, compared to its average volume of 12,326. The company has a debt-to-equity ratio of 0.79, a current ratio of 0.15 and a quick ratio of 0.08. The company’s 50-day moving average price is $7.39 and its 200 day moving average price is $8.15. The firm has a market capitalization of $5.23 million, a PE ratio of -0.22 and a beta of 0.26. Moolec Science has a fifty-two week low of $3.08 and a fifty-two week high of $38.55.

Moolec Science (NASDAQ:MLEC) last announced its quarterly earnings data on Thursday, May 14th. The company reported $47.49 earnings per share (EPS) for the quarter. The firm had revenue of $2.62 million during the quarter.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised Moolec Science from a “sell” rating to a “hold” rating in a report on Saturday, May 16th.

Moolec Science Company Profile

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.